Get started

Financials · GOVX

GeoVax Labs Inc. (GOVX) financials

For the twelve months ended Jun 30, 2026, GeoVax Labs Inc. reported $0 of revenue and -$20.43M of net income.

Revenue, TTM
$0
Revenue growth, YoY
-100.0%
Net income, TTM
-$20.43M
Free cash flow, TTM
-$18.37M
Cash
$3.14M
Market cap
$1.7M
Annual revenue$2.49M
FY2016FY2025
Annual net income-$21.46M
FY2016FY2025
Annual free cash flow-$21.50M
FY2017FY2025

GOVX revenue and earnings growth

GOVX revenueQ2 2026$0

Quarter YoY
-100.0%
FY YoY
-37.1%
5Y CAGR
+6.4%

GOVX revenue was $0 in fiscal Q2 2026 (ended Jun 30, 2026), down 100.0% from a year earlier. For the full fiscal 2025 it was $2.49M, down 37.1% from fiscal 2024. Compound annual growth was +6.4% over 5 years.

GOVX net incomeQ2 2026-$4.43M

GOVX net income was -$4.43M in fiscal Q2 2026 (ended Jun 30, 2026), compared with -$5.37M a year earlier. For the full fiscal 2025 it was -$21.46M, compared with -$24.99M in fiscal 2024.

GOVX free cash flowQ2 2026-$3.66M

GOVX free cash flow was -$3.66M in fiscal Q2 2026 (ended Jun 30, 2026), compared with -$4.35M a year earlier. For the full fiscal 2025 it was -$21.50M, compared with -$24.70M in fiscal 2024.

Export CSV

Income statement

Income statement
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
FY2016
Dec 31, 2016
Revenue$2.49M$3.95M$0$81.5K$385.5K$1.82M$1.18M$963.2K$1.08M$828.9K
Research and development$18.12M$23.71M$20.72M$9.12M$15.55M$2.44M$1.91M$1.88M$2.02M$1.97M
Selling, general and admin$6.01M$5.39M$6.02M$4.99M$3.58M$2.20M$1.64M$1.65M$1.23M$2.13M
Operating income-$21.64M-$25.14M-$26.74M-$14.03M-$18.75M-$2.82M-$2.37M-$2.56M-$2.17M-$3.27M
Interest expense$0$21.4K$0$0$1.3K$143.5K$4.5K$2.6K--
Income tax$0---$0$0$0$0$0$0
Net income-$21.46M-$24.99M-$25.97M-$14.02M-$18.57M-$2.96M-$2.37M-$2.56M-$2.17M-$3.27M
EPS, basic-$22.40-$120.46-$14.29-$12.39-$3.04-$2.14-$781.87-$312206.60-$0.60-$1.60
EPS, diluted-----$3.04-$2.14-$781.87-$312206.60-$0.60-$1.60
Diluted shares----6.1M1.4M3,0328.23.4M2.1M

Balance sheet

Balance sheet
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
FY2016
Dec 31, 2016
Cash and equivalents$3.09M$5.51M$6.45M$27.61M$11.42M$9.88M$283.3K$259.7K$312.7K$454.0K
Receivables$0$659.4K$0-------
Current assets$5.31M$7.93M$7.89M$28.94M$11.63M$10.24M$447.3K$619.7K$448.1K$544.4K
Total assets$6.34M$8.16M$9.28M$31.35M$11.80M$10.39M$468.9K$642.1K$490.2K$610.2K
Current liabilities$1.94M$3.11M$3.52M$4.75M$5.44M$810.3K$2.02M$1.62M$811.3K$369.8K
Total liabilities$2.52M$3.11M-$4.75M$7.44M$825.0K$2.04M$1.66M$811.3K-
Shareholders' equity$3.83M$5.05M$5.76M$26.60M$4.36M$9.57M-$1.57M-$1.02M-$321.1K$240.4K

Cash flow

Cash flow
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
FY2016
Dec 31, 2016
Operating cash flow-$21.47M-$24.68M-$25.17M-$19.03M-$11.20M-$2.75M-$1.40M-$1.54M-$1.69M-$1.95M
Capital expenditures$27.6K$20.7K$48.9K$134.3K$47.7K$156.8K$7.6K-$4.3K-
Free cash flow-$21.50M-$24.70M-$25.22M-$19.16M-$11.24M-$2.91M-$1.41M--$1.69M-
Investing cash flow-$27.6K-$20.7K-$48.9K-$134.3K-$47.7K-$156.8K-$7.6K--$4.3K-
Financing cash flow$19.08M$23.75M$4.06M$35.35M$12.78M$12.51M$1.43M$1.49M$1.55M$1.34M
Stock-based compensation$1.12M$528.6K$1.07M$902.1K$370.0K$64.5K$327.5K$469.7K$57.2K$967.7K
Depreciation and amortization$68.8K$95.4K$74.2K$56.3K$38.5K$19.7K$8.3K$19.8K$28.0K$28.8K

Key ratios

Key ratios
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
FY2016
Dec 31, 2016
Revenue growth, YoY-37.1%--100.0%-78.9%-78.9%55.1%22.1%-10.4%29.7%-
Operating margin-869.3%-635.8%--17207.5%-4862.7%-154.5%-201.8%-266.1%-202.2%-394.9%
Net margin-862.3%-632.0%--17198.3%-4817.2%-162.2%-201.6%-265.8%-201.8%-394.7%
Free cash flow margin-863.8%-624.5%--23507.2%-2916.8%-159.4%-119.6%--157.4%-
Return on equity-561.2%-495.0%-450.6%-52.7%-425.8%-30.9%----1361.1%
Return on assets-338.5%-306.4%-279.7%-44.7%-157.4%-28.5%-505.6%-398.7%-442.7%-536.2%
Current ratio2.742.552.246.102.1412.630.220.380.551.47

Source: XBRL data GeoVax Labs Inc. files with the SEC, latest filing dated Jul 27, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures and share counts are restated for stock splits the filings show: 1-for-20, first reported Mar 23, 2021.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

GOVX peers

CompanyRevenueGrowthNet incomeNet marginMarket cap
GOVX$0-100.0%-$20.43M-$1.7M
LLY$86.46B+45.5%$27.58B31.9%$1.33T
JNJ$99.33B+7.8%$16.09B16.2%$679.13B
ABBV$66.01B+10.7%$10.34B15.7%$518.44B
MRK$67.38B+4.9%$2.45B3.6%$366.73B
NVS$54.53B+8.4%$13.98B25.6%$312.35B
AZN$58.74B+8.6%$10.22B17.4%$293.69B
ABT$48.23B+10.0%$4.70B9.7%$191.40B
NVODKK 309.06B+6.4%DKK 102.43B33.1%$183.23B

GOVX FAQ

7 questions
  • What is GOVX revenue?
    GeoVax Labs Inc. (GOVX) reported $0 of revenue for the twelve months ended Jun 30, 2026. That is down 100.0% from the year before. Revenue for fiscal 2025 was $2.49M.
  • Is GOVX profitable?
    No. GeoVax Labs Inc. reported a net loss of $20.43M for the twelve months ended Jun 30, 2026.
  • How much cash and debt does GOVX have?
    GeoVax Labs Inc. reported $3.14M in cash and cash equivalents on its most recent balance sheet in SEC filings.
  • How fast is GOVX revenue growing?
    GeoVax Labs Inc.'s revenue changed -37.1% in fiscal 2025, to $2.49M. Its compound annual growth rate was +6.4% over 5 years.
  • What is GOVX free cash flow?
    GeoVax Labs Inc. generated -$18.37M of free cash flow for the twelve months ended Jun 30, 2026, which is operating cash flow of -$18.37M less capital expenditures.
  • When did GOVX last report financial results?
    The latest statements here come from GeoVax Labs Inc.'s 10-Q filed on Jul 27, 2026, covering the period ended Jun 30, 2026.
  • Where does this GOVX financial data come from?
    Quantisnow builds these statements from the structured XBRL data GeoVax Labs Inc. files with the SEC. It is provided for information only and is not investment advice.